RxDoctor Payments Data

Thomas Kole

Radiation Oncology · Middletown, NJNPI 1598064545

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Brainlab, Inc. at 55.7% of the total. Reporting peaked in 2023 at $3,035 and has fallen 87.1% since, to $391 in 2025. Among radiation oncology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,395in general payments, 2019–2025

Across 68 payments — averaging $123.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Brainlab, Inc.$5K
  • Novocure Inc.$2K
  • Boston Scientific$414
  • Zap Surgical Systems, Inc.$316
  • Elekta, Inc.$316
  • Accuray Incorporated$134
  • plus $306 from 8 others
$27,692in research payments, 2019–2025

Across 6 payments — averaging $4615.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma America, Inc.$28K

What the payments were for

  • Consulting fees$1,50018%
  • Speaking & faculty fees$1,00012%
  • Travel & lodging$2,32428%
  • Food & beverage$3,57143%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,395 in reported general payments places this provider in the 90th percentile of 132 radiation oncology providers in New Jersey.

See all radiation oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$300,492
Medicare patients
293
Services billed
2,382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl317$4,682
Dexamethasone76$399
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim62$135
Ciprofloxacin Hcl13$40

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Middletown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →